18F-Fluciclovine PET/CT A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma

被引：1

作者：

Marcus, Charles ^{[1
]}

Schuster, David M. ^{[1
]}

Tajmir, Shahein Holmes ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA USA

来源：

CLINICAL NUCLEAR MEDICINE | 2022年 / 47卷 / 09期

关键词：

F-18-fluciclovine; multiple myeloma; PET/CT; prostate cancer; POSITRON-EMISSION-TOMOGRAPHY;

D O I：

10.1097/RLU.0000000000004271

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Incidental concomitant second primary malignancy may be detected on PET/CT imaging. We present an F-18-fluciclovine PET/CT of a patient undergoing evaluation of biochemically recurrent prostate cancer with incidental radiotracer uptake within lytic osseous lesions confirmed to be multiple myeloma. We present the F-18-fluciclovine PET/CT images of an 83-year-old man with prostate cancer treated in 2005 who presented with back pain and a CT scan revealing multiple lytic osseous lesions concerning for metastases versus a plasma cell neoplasm. Prostate-specific antigen at the time of evaluation was 0.1 ng/mL.

引用

页码：E613 / E615

页数：3

共 50 条

[31] 18F-Fluciclovine Uptake in Celiac Ganglia A Pitfall in Prostate Cancer PET Imaging
Wo, Sean
Matesan, Manuela Cristina
CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 743 - 745
[32] Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer
Baiomy, Ali
Jensen, Corey T.
Ward, John F.
Chasen, Beth A.
Ravizzini, Gregory C.
CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 355 - 357
[33] Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
Abiodun-Ojo, Olayinka A.
Jani, Ashesh B.
Akintayo, Akinyemi A.
Akin-Akintayo, Oladunni O.
Odewole, Oluwaseun A.
Tade, Funmilayo I.
Joshi, Shreyas S.
Master, Viraj A.
Fielder, Bridget
Halkar, Raghuveer K.
Zhang, Chao
Goyal, Subir
Goodman, Mark M.
Schuster, David M.
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 1089 - 1096
[34] 18F-Fluciclovine Uptake in Acute Appendicitis
Ahn, Grace S.
Barsky, Andrew R.
Galperin-Aizenberg, Maya
Vapiwala, Neha
Pantel, Austin R.
CLINICAL NUCLEAR MEDICINE, 2020, 45 (10) : E453 - E454
[35] 18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard A Systematic Review
Seierstad, Therese
Hole, Knut Hakon
Tulipan, Andreas Julius
Stromme, Hilde
Lilleby, Wolfgang
Revheim, Mona-Elisabeth
Hernes, Eivor
PET CLINICS, 2021, 16 (02) : 167 - 176
[36] 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
Rais-Bahrami, Soroush
Efstathiou, Jason A.
Turnbull, Catriona M.
Camper, Stephen B.
Kenwright, Andy
Schuster, David M.
Scarsbrook, Andrew F.
PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 997 - 1006
[37] Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer
Baiomy, Ali
Schellingerhout, Dawid
Chapin, Brian F.
Weinberg, Jeffrey S.
Raza, Shaan M.
Macapinlac, Homer
Ravizzini, Gregory
NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (07) : 755 - 762
[38] The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
Wang, Rang
Shen, Guohua
Huang, Mingxing
Tian, Rong
FRONTIERS IN ONCOLOGY, 2021, 11
[39] Isolated Intravascular Prostate Carcinoma Recurrence Confirmed With 18F-Fluciclovine PET/CT and MRI
Agely, Ali
Sharma, Akash
Parent, Ephraim E.
Nawaz, Anem
Jain, Manoj K.
CLINICAL NUCLEAR MEDICINE, 2020, 45 (06) : 442 - 443
[40] Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
Bach-Gansmo, Tore
Korsan, Katrine
Bogsrud, Trond Velde
TOMOGRAPHY, 2022, 8 (03) : 1477 - 1484

← 1 2 3 4 5 →